Project Grant 2321624

Award Date 7/15/23
Completion Date 6/30/27
Dollars Obligated $1.1M
Federal Grant Program
47.074
Assistance Type
Project Grant
Place of Performance
Pittsburgh, PA 15260, USA
Similar Awards
The National Science Foundation (NSF) awarded a $131,176 Project Grant under the Biological Sciences program (CFDA 47.074) to the University of Utah Office of Sponsored Projects Division. The grant funds collaborative research on how a class of proteins called alpha-arrestins regulate nutrient transport and metabolism in eukaryotic cells. Key objectives include determining how loss of alpha-arrestins impacts cellular physiology and mitochondrial function, and developing undergraduate research...
The National Science Foundation (NSF) Division of Molecular and Cellular Biosciences awarded Emory University a $724,356 Project Grant under the Biological Sciences program (CFDA 47.074) to investigate the role of the protein ARL13B in controlling ciliary cyclic AMP (cAMP) signaling. The research aims to unravel the ciliary cAMP "signature", optogenetically stimulate cAMP signaling within normal and ARL13B-excluded cilia, investigate the role of ciliary cAMP signaling in remodeling...
The University of Pittsburgh received a four-year, $855,989 Project Grant from the National Science Foundation Division of Molecular and Cellular Biosciences under the Biological Sciences federal grant program (CFDA 47.074). The grant will fund collaborative research between the University of Pittsburgh and other institutions to tackle functional protein states at atomic detail by integrating weighted ensemble simulations with magnetic resonance restraints. Over the period from July 2021 to June...
The National Science Foundation awarded a $138,000 Project Grant to support research activities from November 1, 2021 to October 31, 2023 under the Biological Sciences program (CFDA 47.074). The grant funding will enable the grantee to conduct research at the University of Pittsburgh aimed at furthering understanding of the evolution of gene regulatory networks through empirical and theoretical approaches. The Biological Sciences program seeks to advance the field and strengthen the national...
The National Science Foundation (NSF) Division of Molecular and Cellular Biosciences awarded a $949,953 Project Grant to the Research Foundation Of The City University Of New York, doing business as Rfcuny - Hunter College, from August 1, 2023 to July 31, 2026. The grant, funded under the Biological Sciences program (CFDA 47.074), will support research to identify molecular interactions and build a detailed model of translational regulation, specifically examining the role of eIF3 and 4E-BP in...
This Project Grant award from the National Science Foundation's Division of Molecular and Cellular Biosciences under the Biological Sciences program (CFDA 47.074) provides $949,958 in funding to Rutgers, The State University of New Jersey, Camden Division to conduct research on the role of inorganic polyphosphate (polyP) in regulating mitochondrial physiology in mammals. The project aims to elucidate the molecular mechanisms by which polyP influences mitochondrial bioenergetics in normal and...
The National Science Foundation Division of Molecular and Cellular Biosciences awarded a $1,050,082 Project Grant to the University of Pittsburgh to support research titled "The Virtues of Lanthanides and Fluorine for Tracking In-Cell Protein Conformation: A Marriage of NMR and EPR" from June 1, 2021 to May 31, 2025. This Project Grant funding will support research under the Biological Sciences federal grant program (CFDA 47.074) to advance understanding of major biological problems....
This $900,052 Project Grant from the National Science Foundation's Division of Molecular and Cellular Biosciences will fund research into the molecular mechanisms governing cytoskeleton-mediated motility and distribution of peroxisomes and mitochondria in plants. The grant supports three years of collaborative research between Michigan State University and its sub-awardee to advance understanding of how these organelles recruit cytoskeletal motor proteins for directional transport along...
The National Science Foundation awarded a $138,000 Project Grant to support research from June 2021 to May 2023 titled "Uncovering the Molecular Mechanisms of Mitochondrial Proteostasis." The grant was awarded under the Biological Sciences program (CFDA 47.074), which aims to promote progress in the biological sciences and strengthen the Nation's scientific enterprise through increasing knowledge and enhancing understanding of major problems. Funds will support the grantee's research...
The National Science Foundation (NSF) Division of Molecular and Cellular Biosciences awarded a $590,000 Project Grant to the University of California Irvine (UC Irvine) on August 15, 2023 under the Biological Sciences program (CFDA 47.074). The goal of this 3-year research project is to develop novel strategies for real-time metabolite sensing and metabolite-induced enzyme localization that can contribute to fundamental cellular knowledge and improve the efficiency of synthetic biology...

The National Science Foundation (NSF) Division of Molecular and Cellular Biosciences awarded a $1,068,821 Project Grant to the University of Pittsburgh for the project "Collaborative Research: Alpha-Arrestins' Impact on Cellular Physiology." This research, conducted under the NSF Biological Sciences program (CFDA 47.074), focuses on understanding how a class of proteins called alpha-arrestins regulate nutrient transporters to maintain metabolite balance and mitochondrial function in eukaryotic cells. The project aims to transform the understanding of alpha-arrestin function, define their impact on cellular metabolism and mitochondrial activity, and develop educational activities to engage undergraduate, graduate, and high school students in this research. Key activities include mapping metabolic changes in cells with impaired alpha-arrestins, defining the nutrient transporters regulated by alpha-arrestins, and using high-content microscopy to link alpha-arrestin-mediated transporter trafficking to mitochondrial form and function. The grant period runs from July 2023 to June 2027.

Generated 4/16/24, 1:55 AM